منابع مشابه
Stroke: 30 years of progress.
In 3 decades, Stroke has evolved from a fledgling publication to the leading journal in the field. Many factors have contributed to this, particularly the succession of outstanding editors in chief. We begin a series on “Stroke: 30 Years of Progress,” wherein each editor recalls the highlights of his tenure, providing a unique view of the past 3 decades (see page 3 for Dr Millikan’s editorial)....
متن کاملAustralian Twin Registry: 30 years of progress.
The Australian Twin Registry (ATR) is a national volunteer resource of twin pairs and higher-order multiples willing to consider participating in health, medical, and scientific research. The vision of the ATR is 'to realize the full potential of research involving twins to improve the health and well-being of all Australians'. The ATR has been funded continuously by the National Health and Med...
متن کاملCO2 EOR and Storage in Oil Reservoirs
CO2 EOR and Storage in Oil Reservoirs — CO2 injection into tertiary oil reservoirs has been widely accepted as an effective technique for enhanced oil recovery (EOR), and has been used by the oil industry for over 40 years. Concerns over greenhouse gas emissions are leading to the investigation and realisation of its potential as a carbon storage method in recent years. With the right reservoir...
متن کاملHIV/AIDS: 30 years of progress and future challenges.
Acquired immune deficiency syndrome (AIDS) was first described 30 years ago in a report from the US Centers for Disease Control. Two years later the causative virus was identified and afterwards named the human immunodeficiency virus (HIV). This article reviews the progress made in the three decades since the recognition of AIDS and the discovery of HIV, with respect to the virus, the infected ...
متن کاملCannabinoid physiology and pharmacology: 30 years of progress.
Delta9-Tetrahydrocannabinol from Cannabis sativa is mimicked by cannabimimetic analogs such as CP55940 and WIN55212-2, and antagonized by rimonabant and SR144528, through G-protein-coupled receptors, CB1 in the brain, and CB2 in the immune system. Eicosanoids anandamide and 2-arachidonoylglycerol are the "endocannabinoid" agonists for these receptors. CB1 receptors are abundant in basal ganglia...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of the Japanese Association for Petroleum Technology
سال: 2011
ISSN: 0370-9868,1881-4131
DOI: 10.3720/japt.76.476